CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), announced ...
CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable”) a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System (OBDS), announced ...
Over the last 5 years, the share price of Enfuse Solutions has gained 14.78% CAGR. Over the past year, the corresponding return has been -3.14%. Enfuse Solutions’s current P/E of 0.00x helps give ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Choosing between multiple stocks can be challenging -- especially when they belong to different sectors. Moneycontrol’s Compare Stocks tool makes this easier by letting you analyse up to three ...
Enable Injections is a combination product company that is synonymous with large-volume wearable injectors. When biopharma companies want to make their biologics more convenient for patients, they ...
Enfuse Group has appointed Alex Mosley as a principal. He arrives supporting the retail and hospitality team. CEO Graeme Curwen commented, “Alex brings strategic vision and sector expertise that will ...
CINCINNATI, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System, today announced ...
Return on investment - most recent fiscal year 8.18 ...
Total Long Term Debt 5.52 6.84 0.00 1.82 ...
Abstract: I welcome you to the fourth issue of the IEEE Communications Surveys and Tutorials in 2021. This issue includes 23 papers covering different aspects of communication networks. In particular, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback